XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Mar. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
CURRENT ASSETS:          
Cash and cash equivalents $ 9,535 $ 16,932   $ 19,064  
Marketable securities 19,374 19,591   75,135  
Accounts receivable, net 67 131   617  
Inventories, net 557 583   4,553  
Prepaid and other current assets 1,745 2,517   6,181  
Total current assets 31,278 39,754   105,550  
Operating lease right-of-use assets 10,862 11,226   15,502  
Property and equipment, net 339 281   7,665  
Restricted Cash, Noncurrent 2,150 2,150   2,150  
Other noncurrent assets 798 906   2,473  
Total assets 45,427 54,317   133,340  
Liabilities, Current [Abstract]          
Accounts payable 3,751 3,442   3,218  
Accrued Expenses and Other Current Liabilities 5,239 6,585   9,764  
Total current liabilities 8,990 10,027   22,563  
Operating lease liabilities, non-current 14,464 14,858   16,681  
Other noncurrent liabilities 49 409   126  
Total liabilities 23,503 25,294   39,370  
COMMITMENTS AND CONTINGENCIES (Note 15)    
STOCKHOLDERS’ EQUITY:          
Preferred stock—$0.0001 par value: 1,000,000 shares authorized; no shares issued and outstanding 0 0   0  
Common stock—$0.0001 par value: 600,000,000 shares authorized; 6,503,019 and 6,310,090 shares issued and outstanding at March 31, 2024 and December 31, 2023 1 1   1  
Additional paid-in capital 369,781 366,647   345,757  
Accumulated other comprehensive (loss) income (4) 10   (1,279)  
Accumulated deficit (347,854) (337,635)   (250,509)  
Total stockholders’ equity 21,924 29,023 $ 75,966 93,970 $ 168,767
Total liabilities and stockholders’ equity $ 45,427 $ 54,317   $ 133,340